Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Disneyland sells out of most expensive Magic Key annual passes
Disneyland has halted sales of the most expensive Magic Key passes as the on again, off again sale of annual passes shows ...